Differences in knowledge, attitudes and intentions towards HPV vaccination among young adults from diverse socio-cultural groups in Israel: A cross-sectional study

In Israel, The Human Papilloma Virus (HPV) vaccine is recommended to both genders up to age 26. Many 18–26 olds missed their opportunity for vaccination during school. Our study described HPV knowledge, attitudes and vaccination intentions among unvaccinated 18–26 Israeli adults across various demographics, aiming to inform future catch-up vaccination strategies. We recruited participants through an anonymous survey and collected information about demographics and HPV knowledge, attitudes and intentions using questions from validated questionnaires adapted to the Israeli context, distributed between December 2023–February 2024. We calculated weighted mean knowledge and attitude scores according to age, gender, ethnicity and sexual orientation. We determined factors associated with vaccination knowledge, attitudes and intentions using multivariate linear regressions. Of 4324 respondents, 36 % were vaccinated. Of 1994 unvaccinated individuals included in the final analysis,